Administrative Core
行政核心
基本信息
- 批准号:10595065
- 负责人:
- 金额:$ 26.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-21 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesAdvocateAwardAwarenessCollaborationsCommunicationCommunitiesDatabasesDevelopmentDevelopmental ProcessEducational workshopEnsureEnvironmentEpidemicFeedbackFosteringFundingGoalsHuman ResourcesIncomeInstitutionInterdisciplinary StudyLeadLeadershipLearningMaintenanceMissionMonitorNational Institute of Allergy and Infectious DiseasePersonnel ManagementPersonsPoliciesPolicy MakerProceduresProcessProductivityResearchResearch PersonnelResourcesScienceService provisionServicesSiteStrategic PlanningSurveysTrainingTuberculosisVisionWorkadvocacy organizationsequipment acquisitionglobal healthmeetingsmembermultidisciplinarynext generationprogramsrecruitsuccesssymposiumsynergismweb siteworking group
项目摘要
PROJECT SUMMARY (ADMINISTRATIVE CORE)
The Administrative Core will lead SEA-TRAC and assume responsibility for strategic planning and
operational management. Aim 1 is focused on enabling the conduct of the best TB science and the development
of the next generation of TB research leaders. This will be accomplished in three subaims. First, we will define,
implement, and continuously refine our strategic plan by regularly convening our multi-disciplinary leadership
team and obtaining and implementing feedback from our user community and Internal and External Advisory
Committees. Second, we will promote an environment to grow collaboration and respond to emerging needs.
This will be accomplished through seminars, workshops, and conferences that bring our diverse community
together to learn and foster dialogue that will lead to new collaborations and funding applications. Third, we will
engage in inter-TRAC initiatives by working with the NIAID as well as bi-directional connections to the community
by working with partners, such as Treatment Action Group, to increase public awareness of TB as a global health
problem. In Aim 2, we will provide operational management that ensures ‘added value’ to our TB research
enterprise. This will be accomplished in four subaims. First, we will manage TRAC Cores and Scientific Working
Groups (SWGs) by continuously evaluating and redefining Core utilization and managing the pre- and post-
award process for Developmental Project Awards. Second, we will ensure effective communication between
the Leadership Group, TRAC Members, and Core Users to develop and promote services that add value to our
research enterprise. We will also facilitate communication with NIAID as well as other TRACs. Third, we will
facilitate increased funding and support for TRAC Members by continuing to advocate on their behalf for
increased institutional commitments as well as working with external partners whose mission align with ours.
Finally, we will manage TRAC finances and personnel by establishing and executing rigorous policies and
procedures governing the allocation of funds, compliance monitoring, personnel management, and maintenance
of TRAC Member and Core user databases. As described in the Overall Strategy, the Vision of SEA-TRAC is
to facilitate a decrease in the global burden of TB through training and high-impact multi-disciplinary research.
The Administrative Core will ensure strategic, effective, and efficient leadership to achieve this goal.
项目摘要(行政核心)
行政核心将领导 SEA-TRAC 并负责战略规划和
目标 1 的重点是促进最佳结核病科学的开展和发展。
这将通过三个子目标来实现,首先,我们将定义:
通过定期召开多学科领导会议来实施并不断完善我们的战略计划
团队,获取并实施来自我们的用户社区以及内部和外部咨询的反馈
其次,我们将营造促进合作和应对新需求的环境。
这将通过研讨会、讲习班和会议来实现,这些研讨会、讲习班和会议使我们多元化的社区
共同学习和促进对话,从而带来新的合作和资金申请。
通过与 NIAID 合作以及与社区的双向联系来参与 TRAC 间的举措
与治疗行动小组等合作伙伴合作,提高公众对结核病作为全球健康问题的认识
在目标 2 中,我们将提供运营管理,确保我们的结核病研究“增值”。
这将通过四个子目标来实现:首先,我们将管理 TRAC 核心和科学工作。
小组(SWG)通过不断评估和重新定义核心利用率并管理前后
发展项目奖的颁奖流程 其次,我们将确保双方之间的有效沟通。
领导小组、TRAC 成员和核心用户开发和推广为我们增值的服务
我们还将促进与 NIAID 以及其他 TRAC 的沟通。
通过继续代表 TRAC 成员倡导,促进增加对 TRAC 成员的资助和支持
增加机构承诺,并与使命与我们一致的外部合作伙伴合作。
最后,我们将通过制定和执行严格的政策和措施来管理 TRAC 的财务和人员。
资金分配、合规监控、人员管理和维护的程序
正如总体战略中所述,SEA-TRAC 的愿景是
通过培训和高影响力的多学科研究,促进减轻全球结核病负担。
行政核心将确保战略、有效和高效的领导以实现这一目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHETAN SESHADRI其他文献
CHETAN SESHADRI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHETAN SESHADRI', 18)}}的其他基金
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
脂质特异性 T 细胞在介导结核分枝杆菌保护中的作用
- 批准号:
10415830 - 财政年份:2020
- 资助金额:
$ 26.36万 - 项目类别:
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
脂质特异性 T 细胞在介导结核分枝杆菌保护中的作用
- 批准号:
10633190 - 财政年份:2020
- 资助金额:
$ 26.36万 - 项目类别:
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens
测量人类 T 细胞对分枝杆菌脂质抗原反应的测定方法的资格
- 批准号:
9312745 - 财政年份:2016
- 资助金额:
$ 26.36万 - 项目类别:
Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens
测量人类 T 细胞对分枝杆菌脂质抗原反应的测定方法的资格
- 批准号:
9152421 - 财政年份:2016
- 资助金额:
$ 26.36万 - 项目类别:
The Role of CD1a in Protecting Against Human Tuberculosis
CD1a 在预防人类结核病中的作用
- 批准号:
8127625 - 财政年份:2010
- 资助金额:
$ 26.36万 - 项目类别:
The Role of CD1a in Protecting Against Human Tuberculosis
CD1a 在预防人类结核病中的作用
- 批准号:
8719921 - 财政年份:2010
- 资助金额:
$ 26.36万 - 项目类别:
The Role of CD1a in Protecting Against Human Tuberculosis
CD1a 在预防人类结核病中的作用
- 批准号:
8312393 - 财政年份:2010
- 资助金额:
$ 26.36万 - 项目类别:
The Role of CD1a in Protecting Against Human Tuberculosis
CD1a 在预防人类结核病中的作用
- 批准号:
7959293 - 财政年份:2010
- 资助金额:
$ 26.36万 - 项目类别:
The Role of CD1a in Protecting Against Human Tuberculosis
CD1a 在预防人类结核病中的作用
- 批准号:
8510564 - 财政年份:2010
- 资助金额:
$ 26.36万 - 项目类别:
相似海外基金
Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas
通过合作进行治愈:利用合作团体对抗慢性淋巴细胞白血病和 B 细胞淋巴瘤
- 批准号:
10566833 - 财政年份:2023
- 资助金额:
$ 26.36万 - 项目类别:
NCI Research Specialist/Clinician Scientist Award for Urologic Oncology Research
NCI 泌尿肿瘤研究研究专家/临床科学家奖
- 批准号:
10640470 - 财政年份:2023
- 资助金额:
$ 26.36万 - 项目类别:
NEWBORN SCREENING FOLLOW-UP STUDY OF CONGENITAL CYTOMEGALOVIRUS (CCMV) INFECTION
先天性巨细胞病毒 (CCMV) 感染的新生儿筛查随访研究
- 批准号:
10937099 - 财政年份:2023
- 资助金额:
$ 26.36万 - 项目类别:
Support Mentoring of Early Career Clinical Researchers from Diverse Backgrounds
支持来自不同背景的早期职业临床研究人员的指导
- 批准号:
10797859 - 财政年份:2023
- 资助金额:
$ 26.36万 - 项目类别:
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science
儿科癌症生物学和数据科学交叉领域的放射肿瘤学
- 批准号:
10712290 - 财政年份:2023
- 资助金额:
$ 26.36万 - 项目类别: